1. Home
  2. CVAC vs MTAL Comparison

CVAC vs MTAL Comparison

Compare CVAC & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • MTAL
  • Stock Information
  • Founded
  • CVAC 2000
  • MTAL 2021
  • Country
  • CVAC Germany
  • MTAL Jersey
  • Employees
  • CVAC N/A
  • MTAL N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • MTAL Blank Checks
  • Sector
  • CVAC Health Care
  • MTAL Finance
  • Exchange
  • CVAC Nasdaq
  • MTAL Nasdaq
  • Market Cap
  • CVAC 818.8M
  • MTAL 830.2M
  • IPO Year
  • CVAC 2020
  • MTAL 2021
  • Fundamental
  • Price
  • CVAC $2.72
  • MTAL $9.33
  • Analyst Decision
  • CVAC Hold
  • MTAL Buy
  • Analyst Count
  • CVAC 3
  • MTAL 2
  • Target Price
  • CVAC $10.00
  • MTAL $14.75
  • AVG Volume (30 Days)
  • CVAC 634.5K
  • MTAL 466.5K
  • Earning Date
  • CVAC 05-22-2025
  • MTAL 01-01-0001
  • Dividend Yield
  • CVAC N/A
  • MTAL N/A
  • EPS Growth
  • CVAC N/A
  • MTAL N/A
  • EPS
  • CVAC N/A
  • MTAL N/A
  • Revenue
  • CVAC $70,565,734.00
  • MTAL $340,736,000.00
  • Revenue This Year
  • CVAC $742.57
  • MTAL $24.36
  • Revenue Next Year
  • CVAC N/A
  • MTAL $16.52
  • P/E Ratio
  • CVAC N/A
  • MTAL N/A
  • Revenue Growth
  • CVAC 75.11
  • MTAL 114.30
  • 52 Week Low
  • CVAC $2.22
  • MTAL $9.26
  • 52 Week High
  • CVAC $5.28
  • MTAL $15.26
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 36.80
  • MTAL 34.15
  • Support Level
  • CVAC $2.78
  • MTAL $10.15
  • Resistance Level
  • CVAC $3.33
  • MTAL $10.88
  • Average True Range (ATR)
  • CVAC 0.15
  • MTAL 0.43
  • MACD
  • CVAC -0.01
  • MTAL -0.10
  • Stochastic Oscillator
  • CVAC 1.61
  • MTAL 3.79

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About MTAL Metals Acquisition Limited

MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.

Share on Social Networks: